These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

747 related items for PubMed ID: 7471050

  • 21. Modulation by adriamycin, daunomycin, verapamil, and trifluoperazine of the biochemical processes linked to mouse skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.
    Satyamoorthy K, Perchellet JP.
    Cancer Res; 1989 Oct 01; 49(19):5364-70. PubMed ID: 2475247
    [Abstract] [Full Text] [Related]

  • 22. Ornithine decarboxylase induction and DNA synthesis in hamster embryo cell cultures treated with tumor-promoting phorbol diesters.
    O'Brien TG, Diamond L.
    Cancer Res; 1977 Nov 01; 37(11):3895-900. PubMed ID: 908030
    [Abstract] [Full Text] [Related]

  • 23. Correlation of phorbol ester promotion in the resistant C57BL/6J mouse with sustained hyperplasia but not ornithine decarboxylase or protein kinase C.
    Fischer SM, Jasheway DW, Klann RC, Butler AP, Patrick KE, Baldwin JK, Cameron GS.
    Cancer Res; 1989 Dec 01; 49(23):6693-9. PubMed ID: 2819717
    [Abstract] [Full Text] [Related]

  • 24. Identification of epidermal cell subpopulations with increased ornithine decarboxylase activity following treatment of murine epidermis with 12-O-tetradecanoylphorbol-13-acetate.
    Robertson FM, Gilmour SK, Conney AH, Huang MT, Beavis AJ, Laskin JD, Hietala OA, O'Brien TG.
    Cancer Res; 1990 Aug 01; 50(15):4741-6. PubMed ID: 2369749
    [Abstract] [Full Text] [Related]

  • 25. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-caused tumor promotion in benzo[a]pyrene-initiated CD-1 mouse skin by geniposide.
    Lee MJ, Hsu JD, Wang CJ.
    Anticancer Res; 1995 Aug 01; 15(2):411-6. PubMed ID: 7763014
    [Abstract] [Full Text] [Related]

  • 26. Inhibition of tumor promoter-induced ornithine decarboxylase activity by tannic acid and other polyphenols in mouse epidermis in vivo.
    Gali HU, Perchellet EM, Perchellet JP.
    Cancer Res; 1991 Jun 01; 51(11):2820-5. PubMed ID: 2032222
    [Abstract] [Full Text] [Related]

  • 27. Regulation of ornithine decarboxylase gene expression in mouse epidermis and epidermal tumors during two-stage tumorigenesis.
    Gilmour SK, Verma AK, Madara T, O'Brien TG.
    Cancer Res; 1987 Mar 01; 47(5):1221-5. PubMed ID: 3815331
    [Abstract] [Full Text] [Related]

  • 28. Inhibition by 1 alpha, 25-dihydroxyvitamin D3 of induction of epidermal ornithine decarboxylase caused by 12-O-tetradecanoylphorbol-13-acetate and teleocidin B.
    Chida K, Hashiba H, Suda T, Kuroki T.
    Cancer Res; 1984 Apr 01; 44(4):1387-91. PubMed ID: 6423272
    [Abstract] [Full Text] [Related]

  • 29. Inhibition of skin tumor promotion by retinoic acid and its metabolite 5,6-epoxyretinoic acid.
    Verma AK, Slaga TJ, Wertz PW, Mueller GC, Boutwell RK.
    Cancer Res; 1980 Jul 01; 40(7):2367-71. PubMed ID: 7388798
    [Abstract] [Full Text] [Related]

  • 30. Inhibitory effect of apigenin, a plant flavonoid, on epidermal ornithine decarboxylase and skin tumor promotion in mice.
    Wei H, Tye L, Bresnick E, Birt DF.
    Cancer Res; 1990 Feb 01; 50(3):499-502. PubMed ID: 2105157
    [Abstract] [Full Text] [Related]

  • 31. Ornithine decarboxylase activity and DNA synthesis after treatment of cells in culture with 12-O-tetradecanoylphorbol-13-acetate.
    O'Brien TG, Lewis MA, Diamond L.
    Cancer Res; 1979 Nov 01; 39(11):4477-80. PubMed ID: 498078
    [Abstract] [Full Text] [Related]

  • 32. Effects of single applications of 12-O-tetradecanoylphorbol-13-acetate, mezerein, or ethylphenylpropiolate on DNA synthesis and polyamine levels in hairless mouse epidermis.
    Paulsen JE, Astrup EG.
    Cancer Res; 1983 Sep 01; 43(9):4126-31. PubMed ID: 6871854
    [Abstract] [Full Text] [Related]

  • 33. Effects of flavonoids and antioxidants on 12-O-tetradecanoyl-phorbol-13-acetate-caused epidermal ornithine decarboxylase induction and tumor promotion in relation to lipoxygenase inhibition by these compounds.
    Nakadate T, Yamamoto S, Aizu E, Kato R.
    Gan; 1984 Mar 01; 75(3):214-22. PubMed ID: 6427052
    [Abstract] [Full Text] [Related]

  • 34. Specific binding, stimulation of rodent urinary bladder epithelial ornithine decarboxylase, and induction of transitional cell hyperplasia by the skin tumor promoter 12-O-tetradecanoylphorbol-13-acetate.
    Verma AK, Ertürk E, Bryan GT.
    Cancer Res; 1983 Dec 01; 43(12 Pt 1):5964-71. PubMed ID: 6315223
    [Abstract] [Full Text] [Related]

  • 35. Induction of the polyamine-biosynthetic enzymes in mouse epidermis and their specificity for tumor promotion.
    O'Brien TG, Simsiman RC, Boutwell RK.
    Cancer Res; 1975 Sep 01; 35(9):2426-33. PubMed ID: 807325
    [Abstract] [Full Text] [Related]

  • 36. Differential down-regulation of epidermal protein kinase C by 12-O-tetradecanoylphorbol-13-acetate and diacylglycerol: association with epidermal hyperplasia and tumor promotion.
    Hansen LA, Monteiro-Riviere NA, Smart RC.
    Cancer Res; 1990 Sep 15; 50(18):5740-5. PubMed ID: 2393848
    [Abstract] [Full Text] [Related]

  • 37. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion and epidermal ornithine decarboxylase activity in mouse skin by palmitoylcarnitine.
    Nakadate T, Yamamoto S, Aizu E, Kato R.
    Cancer Res; 1986 Apr 15; 46(4 Pt 1):1589-93. PubMed ID: 3081251
    [Abstract] [Full Text] [Related]

  • 38. Induction of ornithine decarboxylase activity and DNA synthesis in hairless mouse epidermis by retinoids.
    Connor MJ, Lowe NJ.
    Cancer Res; 1983 Nov 15; 43(11):5174-7. PubMed ID: 6616453
    [Abstract] [Full Text] [Related]

  • 39. Inhibition of DNA synthesis and sugar uptake and lack of induction of ornithine decarboxylase in human epidermal cells treated with mouse skin tumor promoters.
    Chida K, Kuroki T.
    Cancer Res; 1984 Mar 15; 44(3):875-9. PubMed ID: 6692409
    [Abstract] [Full Text] [Related]

  • 40. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced epidermal ornithine decarboxylase activity by phospholipase A2 inhibitors and lipoxygenase inhibitor.
    Nakadate T, Yamamoto S, Ishii M, Kato R.
    Cancer Res; 1982 Jul 15; 42(7):2841-5. PubMed ID: 6805948
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 38.